Scaini, G., de Quevedo, J. L., Velligan, D. I., Roberts, D. L., Raventós Vorst, H., & Walss Bass, C. (2018). Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia.

Scaini, Giselli, João Luciano de Quevedo, Dawn I. Velligan, David Leland Roberts, Henriette Raventós Vorst, and Consuelo Walss Bass. Second Generation Antipsychotic-induced Mitochondrial Alterations: Implications for Increased Risk of Metabolic Syndrome in Patients With Schizophrenia. 2018.

Scaini, Giselli, et al. Second Generation Antipsychotic-induced Mitochondrial Alterations: Implications for Increased Risk of Metabolic Syndrome in Patients With Schizophrenia. 2018.